According to Taro Pharmaceutical's latest financial reports the company's total assets are $2.16 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $2.13 B | -1.88% |
2022-03-31 | $2.17 B | -9.58% |
2021-03-31 | $2.40 B | 2.8% |
2020-03-31 | $2.34 B | 9.64% |
2019-03-31 | $2.13 B | -12.24% |
2018-03-31 | $2.43 B | 6.27% |
2017-03-31 | $2.28 B | 4.65% |
2016-03-31 | $2.18 B | 25.91% |
2015-03-31 | $1.73 B | 35.3% |
2014-03-31 | $1.28 B | 16.06% |
2013-03-31 | $1.10 B | |
2011-12-31 | $0.79 B | 43.02% |
2010-12-31 | $0.55 B | -3.38% |
2009-12-31 | $0.57 B | 21.73% |
2008-12-31 | $0.47 B | -2.12% |
2007-12-31 | $0.48 B | 13.81% |
2006-12-31 | $0.42 B | -22.53% |
2005-12-31 | $0.54 B | -21.33% |
2004-12-31 | $0.69 B | 13.03% |
2003-12-31 | $0.61 B | 62.31% |
2002-12-31 | $0.37 B | 23.42% |
2001-12-31 | $0.30 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $171.96 B | 7,849.69% | ๐บ๐ธ USA |
Novartis NVS | $94.33 B | 4,260.89% | ๐จ๐ญ Switzerland |
Pfizer PFE | $221.09 B | 10,120.83% | ๐บ๐ธ USA |
Merck MRK | $105.84 B | 4,793.21% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $73.94 B | 3,318.20% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $42.77 B | 1,877.32% | ๐ฎ๐ฑ Israel |